Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jeffrey G. Lamothe currently holds 41 shares of Aptevo Therapeutics Inc. (APVO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey G. Lamothe has been a net neutral trader of APVO stock. They have purchased $0 and sold $0 worth of shares.
Jeffrey G. Lamothe's most recent insider trade was on Aug 8, 2024, when they sold 42 shares at $0.00 per share.
Jeffrey G. Lamothe serves as Executive at Aptevo Therapeutics Inc. (APVO). They have executed 30 insider transactions totaling $0 over their tenure at the company.
Jeffrey G. Lamothe holds the position of Executive at Aptevo Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Jeffrey G. Lamothe has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Jeffrey G. Lamothe was on Feb 3, 2018, when they sold $24.3K worth of APVO shares. This transaction involved 7,514 shares at $3.24 per share.
Jeffrey G. Lamothe currently owns 41 shares of Aptevo Therapeutics Inc. (APVO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jeffrey G. Lamothe's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jeffrey G. Lamothe has 30 Form 4 filings on record as an insider at Aptevo Therapeutics Inc..
Set alerts for Jeffrey G. Lamothe and 40,000+ other insiders.